Harnessing Immuno-nanotechnology for Therapy of Inflammatory Bowel Disease.

Gastric Control of Intestinal Function.

Synthetic Engineering of Enhanced Fitness and Adhesion Properties in Probiotics for the treatment of Inflammatory Bowel Disease.

Interface Between Antigen-Presenting Cells, Lympahtics, and the Expansion of Adipose Tissue in Inflammatory Intestinal Disease.

Potential of Parasite Products to Suppress Inflammatory Bowel Disease.

Development of a Fecal Microbiota Transplant Mouse Model for Ulcerative Colitis to Identify Pro-and Anti-inflammatory Bacteria.

Identification of Microbial Triggers of Colitis in Genetically Relevant, Transmissible Mouse Model.

A Novel Mouse Model to Study the Molecular Basis of Chronic Inflammation in Inflammatory Bowel Disease.

Bioengineering Bacterially Derived Immunomodulants: A Novel Therapeutic Approach to IBD.

Interface Between Antigen-Presenting Cells, Lympahtics, and the Expansion of Adipose Tissue in Inflammatory Intestinal Disease.